证券代码：300107 证券简称：建新股份 公告编号：2025-023 河北建新化工股份有限公司 关于调整股票期权行权价格的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 3、2022 年 6 月 16 日至 2022 年 6 月 25 日，公司对授予激励对象名单的姓 名和职位在公司内部进行了公示，在公示期内，公司监事会未接到与本激励计划 拟激励对象有关的任何异议。2022 年 6 月 26 日，公司披露了《监事会关于公司 2022 年股票期权与限制性股票激励计划激励对象名单的公示情况说明及核查意 1 见》。 4、2022 年 7 月 1 日，公司召开 2022 年第一次临时股东大会，审议通过了 《关于<公司 2022 年股票期权与限制性股票激励计划（草案）>及其摘要的议 案》、《关于<公司 2022 年股票期权与限制性股票激励计划实施考核管理办法> 的议案》、《关于提请股东大会授权董事会办理公司 2022 年股票期权与限制性 股票激励计划相关事宜的议案》等议案，并披露了《关于 2022 年股票期权与限 制性股票激励计划内幕信息知情人及激励对象买卖公司股 ...

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

Summary of Key Points Core Viewpoint - The announcement details the share reduction plans of several directors and senior management of Hebei Jianxin Chemical Co., Ltd, indicating a total planned reduction of 3,659,100 shares, which represents 0.65% of the company's total share capital [1][4]. Group 1: Shareholders' Reduction Plans - Director Chen Xuewei plans to reduce his holdings by 1,744,600 shares, accounting for 0.31% of the total share capital [4]. - Director Zhu Xiuquan intends to reduce his holdings by 1,686,400 shares, representing 0.30% of the total share capital [4]. - Director Xu Guangwu plans to reduce his holdings by 114,300 shares, which is 0.02% of the total share capital [4]. - Senior Engineer Liu Jiawei plans to reduce his holdings by 67,500 shares, accounting for 0.01% of the total share capital [4]. - Deputy General Manager Zhang Guihai intends to reduce his holdings by 46,300 shares, representing 0.01% of the total share capital [4]. Group 2: Shareholding Structure - Chen Xuewei holds a total of 6,978,469 shares, which is 1.24% of the total share capital [3]. - Zhu Xiuquan holds 6,745,724 shares, accounting for 1.20% of the total share capital [3]. - Xu Guangwu holds 457,500 shares, representing 0.08% of the total share capital [3]. - Liu Jiawei holds 270,000 shares, which is 0.05% of the total share capital [3]. - Zhang Guihai holds 185,250 shares, accounting for 0.03% of the total share capital [3]. Group 3: Compliance and Commitments - The directors and senior management have committed to not transferring their shares within specified periods following the company's public offering, with Chen Xuewei and Zhu Xiuquan having specific lock-up periods of 12 and 36 months, respectively [5]. - All involved parties have adhered to their commitments without any violations as of the announcement date [5].

高级管理人员刘佳伟先生计划在本公告披露之日起十五个交易日后的三个月内（自2025年6月17日至 2025年9月16日，法律法规禁止减持的窗口期间不减持。），通过集中竞价方式减持公司股份67,500股 （占公司总股本比例0.01%）。 董事/高级管理人员朱秀全先生计划在本公告披露之日起十五个交易日后的三个月内（自2025年6月17日 至2025年9月16日，法律法规禁止减持的窗口期间不减持。），通过集中竞价方式减持公司股份 1,686,400股（占公司总股本比例0.30%）。 董事/高级管理人员徐光武先生计划在本公告披露之日起十五个交易日后的三个月内（自2025年6月17日 至2025年9月16日，法律法规禁止减持的窗口期间不减持。），通过集中竞价方式减持公司股份114,300 股（占公司总股本比例0.02%）。 格隆汇5月25日丨建新股份(300107.SZ)公布，公司近日收到董事/高级管理人员陈学为先生、朱秀全先 生、徐光武先生和高级管理人员刘佳伟先生、张贵海先生提交的《股份减持计划告知函》。现将有关情 况公告如下： 高级管理人员张贵海先生计划在本公告披露之日起十五个交易日后的三个月内（自2025年6月17 ...

证券代码：300107 证券简称：建新股份 公告编号：2025-020 河北建新化工股份有限公司 关于董事、高级管理人员减持股份预披露公告 董事/高级管理人员陈学为先生、朱秀全先生、徐光武先生和高级管理人员 刘佳伟先生、张贵海先生保证向本公司提供的信息内容真实、准确、完整， 没 有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 ： 1、持有河北建新化工股份有限公司（以下简称"公司"）股份 6,978,469 股（占公司总股本比例 1.24%）的董事/高级管理人员陈学为先生计划在本公告 披露之日起十五个交易日后的三个月内（自 2025 年 6 月 17 日至 2025 年 9 月 16 日，法律法规禁止减持的窗口期间不减持。），通过集中竞价方式减持公司股 份 1,744,600 股（占公司总股本比例 0.31%）。 2、持有公司股份 6,745,724 股（占公司总股本比例 1.20%）的董事/高级管 理人员朱秀全先生计划在本公告披露之日起十五个交易日后的三个月内（自 2025 年 6 月 17 日至 2025 年 9 ...

申请办理分红派息业务至股权登记日期间，公司 2022 年股权激励计划的激励对象在 第二个行权期暂停自主行权。 证券代码：300107 证券简称：建新股份 公告编号：2025-019 河北建新化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载，误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）2024 年度权益分派方案 已经 2025 年 5 月 13 日召开的 2024 年年度股东大会审议通过，现将权益分派事 宜公告如下： 一、股东大会审议通过权益分配方案情况 金红利 9,001,316.29 元（含税）；不送红股，不进行资本公积金转增股本，剩 余未分配利润结转下一年度分配。 年股权激励计划的第二个行权期激励对象自主行权 2,600 股，公司总股本由 对现金分红总额进行调整。2024 年度权益分派方案调整为：以公司现有总股本 配利润结转下一年度分配。 整原则一致。 个月。 二、权益分派方案 本公司 2024 年年度权益分派方案为：以公司现有总股本 562,584,868 股为 基数，向全体股东每 10 股派 0.160000 元人民币现金（含税；扣税后 ...

证券代码：300107 证券简称：建新股份 公告编号：2025-019 河北建新化工股份有限公司 2024年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载，误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）2024 年度权益分派方案 已经 2025 年 5 月 13 日召开的 2024 年年度股东大会审议通过，现将权益分派事 宜公告如下： 一、股东大会审议通过权益分配方案情况 1、公司 2024 年度权益分配方案为：公司拟以 2025 年 4 月 10 日总股本 562,582,268 股为基数，按每 10 股派发现金红利 0.16 元（含税），合计派发现 金红利 9,001,316.29 元（含税）；不送红股，不进行资本公积金转增股本，剩 余未分配利润结转下一年度分配。 2、自 2024 年度利润分配预案披露至实施权益分派股权登记日，因公司 2022 年股权激励计划的第二个行权期激励对象自主行权 2,600 股，公司总股本由 562,582,268 股增加至 562,584,868 股，按照"每股现金分红比例不变"的原则 对现金分红总额进行调整 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于河北建新化工股份有限公司 2024 年年度股东大会的 法律意见书 国枫律股字[2025]A0169 号 致：河北建新化工股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2024 年年度股东大会（以下简称"本次会议"）。 4．本法律意见书仅供贵公司本次会议之目的使用，不得用作任何其他用途。本所 律师同意将本法律意见书随贵公司本次会议决议一起予以公告。 本所律师根据《公司法》《证券法》《股东会规则》《证券法律业务管理办法》《证 券法律业务执业规则》等相关法律、行政法规、规章、规范性文件的要求，按照律师行 业公认的业务标准、道德规范和勤勉尽责精神，对贵公司提供的有关文件和有关事项进 行了核查和验证，现出具法律意见如下： 一、本次会议的召集、召开程序 （一）本次会议的召集 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《 ...

河北建新化工股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 证劵代码：300107 证劵简称：建新股份 公告编号：2025-018 特别提示： 1、本次股东大会无新增、更改、否决议案的情况； 2、本次股东大会不涉及变更前次股东大会决议的情况。 一、会议召开和出席情况 （一）会议召开情况 1、现场会议召开时间：2025年5月13日（星期二）下午14：00。 2、网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为2025年5月13日的 交易时间，即9：15—9：25，9：30—11：30和13：00—15：00；通过深圳证券 交易所互联网投票系统进行网络投票的时间：2025年5月13日上午9：15至下午15： 00期间的任意时间。 3、会议召开地点：河北省沧州市清池南大道8号建新大厦8楼公司会议室。 4、会议召开方式：现场投票、网络投票相结合的方式。 5、会议召集人：公司董事会 6、会议主持人：董事长朱守琛先生 7、本次股东大会的通知已于2025年4月19日刊登于中国证监会指定创业板信 息披露网站巨潮资 ...

Industry Overview - The insulation products industry in China has developed rapidly since the 1990s, establishing a comprehensive industrial system and becoming the largest insulation products market globally. The market size is projected to reach approximately 77.5 billion yuan in 2024, with a year-on-year growth of 2.79% [1][14]. - The industry has matured technologically, with leading companies capable of developing high-end insulation products, gaining competitive advantages in international markets [1][14]. Market Dynamics - The insulation products are essential components in electrical equipment and electronic devices, serving various functions such as mechanical support, heat dissipation, and moisture protection [3]. - The industry benefits from the rapid development of sectors like renewable energy, efficient energy-saving motors, and rail transportation, contributing to a relatively prosperous market environment [5]. Policy Environment - Recent policies have been introduced to support the insulation products industry, including the "Implementation Plan for Accelerating the Breakthrough of 'Six New' Manufacturing in Henan Province" and the "Implementation Plan for the Innovation and Development of the Fine Chemical Industry (2024-2027)" [5][7]. Industry Chain - The upstream of the insulation products industry includes raw materials such as phenol, formaldehyde, and epoxy resin, which are essential for production. The industry is moving towards high-quality and environmentally friendly production due to supply-side structural reforms [8][10]. - The downstream applications include generator manufacturing, power transmission, new energy vehicles, and electronic communications, with increasing demand driven by the national "dual carbon" goals [8][11]. Key Companies - Notable companies in the insulation products sector include Dongcai Technology, Huazheng New Materials, and Shunma Electric, among others. These companies are focusing on innovation and expanding their market presence [16][19][21]. - Dongcai Technology reported a revenue of 32.45 million yuan in the first quarter of 2024, while Huazheng New Materials achieved 28.24 million yuan in the same period [18]. Development Trends - The industry is expected to focus on technological innovation, particularly in high-performance and environmentally friendly insulation materials. Innovations such as nano-modification and composite insulation technologies are anticipated to gain traction [23][24]. - The shift towards green and sustainable practices is becoming a priority, with increasing demand for halogen-free and biodegradable insulation materials [24][25]. Conclusion - The insulation products industry in China is poised for growth, driven by technological advancements, supportive policies, and expanding applications across various sectors. The competitive landscape is evolving, with both international giants and domestic players striving for market share through innovation and quality improvements [16][23].